Literature DB >> 28439644

Have biomarkers failed in acute kidney injury? No.

Blaithin A McMahon1, Jay L Koyner2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28439644     DOI: 10.1007/s00134-017-4792-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.

Authors:  Jay L Koyner; Danielle L Davison; Ermira Brasha-Mitchell; Divya M Chalikonda; John M Arthur; Andrew D Shaw; James A Tumlin; Sharon A Trevino; Michael R Bennett; Paul L Kimmel; Michael G Seneff; Lakhmir S Chawla
Journal:  J Am Soc Nephrol       Date:  2015-02-05       Impact factor: 10.121

Review 2.  Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.

Authors:  Rakesh Malhotra; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-08       Impact factor: 8.237

3.  Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.

Authors:  Thomas L Nickolas; Kai M Schmidt-Ott; Pietro Canetta; Catherine Forster; Eugenia Singer; Meghan Sise; Antje Elger; Omar Maarouf; David Antonio Sola-Del Valle; Matthew O'Rourke; Evan Sherman; Peter Lee; Abdallah Geara; Philip Imus; Achuta Guddati; Allison Polland; Wasiq Rahman; Saban Elitok; Nasir Malik; James Giglio; Suzanne El-Sayegh; Prasad Devarajan; Sudarshan Hebbar; Subodh J Saggi; Barry Hahn; Ralph Kettritz; Friedrich C Luft; Jonathan Barasch
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

4.  Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR.

Authors:  Jay L Koyner; Steven G Coca; Heather Thiessen-Philbrook; Uptal D Patel; Michael G Shlipak; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2015-09-16       Impact factor: 8.860

5.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.

Authors:  Alexander Zarbock; John A Kellum; Christoph Schmidt; Hugo Van Aken; Carola Wempe; Hermann Pavenstädt; Andreea Boanta; Joachim Gerß; Melanie Meersch
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

Review 6.  Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough?

Authors:  Blaithin A McMahon; Jay L Koyner
Journal:  Adv Chronic Kidney Dis       Date:  2016-05       Impact factor: 3.620

7.  Linking injury to outcome in acute kidney injury: a matter of sensitivity.

Authors:  John W Pickering; Zoltan H Endre
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Subclinical AKI is still AKI.

Authors:  Claudio Ronco; John A Kellum; Michael Haase
Journal:  Crit Care       Date:  2012-06-21       Impact factor: 9.097

9.  Development and standardization of a furosemide stress test to predict the severity of acute kidney injury.

Authors:  Lakhmir S Chawla; Danielle L Davison; Ermira Brasha-Mitchell; Jay L Koyner; John M Arthur; Andrew D Shaw; James A Tumlin; Sharon A Trevino; Paul L Kimmel; Michael G Seneff
Journal:  Crit Care       Date:  2013-09-20       Impact factor: 9.097

10.  Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial.

Authors:  Orla M Smith; Ron Wald; Neill K J Adhikari; Karen Pope; Matthew A Weir; Sean M Bagshaw
Journal:  Trials       Date:  2013-10-05       Impact factor: 2.279

View more
  2 in total

1.  Biomarkers in acute kidney injury: that's all the story? : Discussion on "Have biomarkers failed in acute kidney injury?"

Authors:  Roberta Meroni; Marco Simonini; Nunzia Casamassima; Elena Bignami; Jay L Koyner
Journal:  Intensive Care Med       Date:  2017-08-29       Impact factor: 17.440

2.  Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective.

Authors:  Benjamin R Griffin; Katja M Gist; Sarah Faubel
Journal:  J Intensive Care Med       Date:  2019-01-17       Impact factor: 3.510

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.